IGMs Indole Glucosinolate Metabolites
Description: <h3>Indole Glucosinolate Metabolites</h3>
<p>
Indole glucosinolate metabolites are bioactive compounds
formed from indole-containing glucosinolates in
cruciferous vegetables. Glucobrassicin is hydrolyzed
by myrosinase, producing indole-3-carbinol (I3C),
which can undergo acid-dependent condensation in
the stomach to form diindolylmethane (DIM) and
other indole derivatives.
</p>
<p>
These compounds are studied for their effects on
estrogen metabolism, aryl hydrocarbon receptor
signaling, cell proliferation, apoptosis and
hormone-responsive cancers.
</p>
<h4>Main Potential Anticancer Mechanisms</h4>
<ul>
<li>
Modulation of estrogen metabolism, including
experimental changes in estrogen hydroxylation.
</li>
<li>
Regulation of aryl hydrocarbon receptor (AhR)
signaling and downstream transcription.
</li>
<li>
Modulation of
<a href="https://nestronics.ca/dbx/tbResList.php?tsv=253">
PI3K/AKT</a> survival signaling.
</li>
<li>
Induction of
<a href="https://nestronics.ca/dbx/tbResList.php?tsv=14">
apoptosis</a>
in experimental cancer models.
</li>
<li>
Induction of
<a href="https://nestronics.ca/dbx/tbResList.php?tsv=322">
cell-cycle arrest</a>.
</li>
<li>
Experimental regulation of inflammatory
and hormone receptor-associated pathways.
</li>
</ul>
<h4>Representative Compounds</h4>
<ul>
<li>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=99">
Indole-3-carbinol (I3C)</a> -
primary indole metabolite of glucobrassicin.
</li>
<li>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=496">
3,3'-Diindolylmethane (DIM)</a> -
acid-condensation product of I3C,
studied for effects on estrogen signaling
and cancer-cell proliferation.
</li>
</ul>
<p><strong>Related Precursor:</strong>
Glucobrassicin, an indole glucosinolate
found in cruciferous vegetables.
</p>
<p><strong>Principal Food Sources:</strong>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=486">
Broccoli</a>, cabbage, kale, cauliflower,
Brussels sprouts and other cruciferous vegetables.
</p>
<p><strong>Evidence:</strong>
Preclinical anticancer studies and limited
human biomarker trials. Evidence does not yet
establish clinical cancer-prevention or
treatment efficacy for I3C or DIM supplements.
</p>